4D Molecular Therapeutics (FDMT) Amortizatization of Intangibles (2021 - 2025)
Historic Amortizatization of Intangibles for 4D Molecular Therapeutics (FDMT) over the last 5 years, with Q3 2025 value amounting to $1.2 million.
- 4D Molecular Therapeutics' Amortizatization of Intangibles fell 4848.21% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 532.82%. This contributed to the annual value of $7.2 million for FY2024, which is 36485.44% up from last year.
- 4D Molecular Therapeutics' Amortizatization of Intangibles amounted to $1.2 million in Q3 2025, which was down 4848.21% from $1.2 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Amortizatization of Intangibles ranged from a high of $2.8 million in Q4 2022 and a low of -$582000.0 during Q1 2022
- In the last 5 years, 4D Molecular Therapeutics' Amortizatization of Intangibles had a median value of $402000.0 in 2023 and averaged $804631.6.
- Examining YoY changes over the last 5 years, 4D Molecular Therapeutics' Amortizatization of Intangibles showed a top increase of 62815.79% in 2022 and a maximum decrease of 25945.21% in 2022.
- 4D Molecular Therapeutics' Amortizatization of Intangibles (Quarter) stood at $380000.0 in 2021, then soared by 628.16% to $2.8 million in 2022, then tumbled by 85.15% to $411000.0 in 2023, then soared by 350.12% to $1.8 million in 2024, then tumbled by 37.62% to $1.2 million in 2025.
- Its Amortizatization of Intangibles stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.